Skip to main content
. 2019 Dec 31;15:3. doi: 10.1186/s13014-019-1454-2

Fig. 3.

Fig. 3

Intracranial Progression-free Survival (a) and Overall Survival (b) of NSCLC developed multiple BMs patients with Lung-molGPA 2.5–4